Escolar Documentos
Profissional Documentos
Cultura Documentos
WHAT IS
MENINGGOCOCCEMIA?
MENINGGOCOCCEMIA is a bacterial infection
A PERSON AFFECTED BY
MENINGGOCOCCEMIA..
CAUSES
Bacteria called Neisseria
Meningitidis
Neisseria Meningitidis- the
bacteria that causes
Meninggococcemia, can
harmlessly live in your UPPER
RESPIRATORY TRACT.
Later symptoms:
Changing level of consciousness
Large areas of bleeding under the skin
Shock
As the disease progresses, you will develop
more serious symptoms. These includes blood
clots and patches of bleeding under your skin.
As the condition progresses, you may be
lethargic or slip into a stupor. You may also go
into shock
HOW IS MENINGGOCOCCEMIA
DIAGNOSED?
MENINGITIS is usually diagnosed through
blood tests.
The doctor might perform the same test using
fluid from your spine instead of your blood. The
test is called CSF (cerebrospinal fluid) culture.
Other tests could be:
Skin biopsy
Blood clotting tests (CBC)
Or get test from your urine
PREVENTION/ treatment
MUST BE TREATED IMMEDIATELY!
Preventive antibiotics for family members and
contacts are often recommended.
Antibiotics through vein
Other treatments depends on the symptoms
A VACCINE that covers some, but not all
strains of Meninggococcemia is recommended
for children.
ADDITIONAL INFORMATION
Meningococcemia is anacuteand potentially lifethreatening infection of the bloodstream.
Possible Complications
Possible complications of this infection are:
Bleeding disorder (DIC)
Gangrene due to lack of blood supply
Inflammation of blood vessels in the skin
Inflammation of the heart muscle
Inflammation of the heart lining
Shock
Severe damage to adrenal glands that can lead to
low blood pressure
INTERVIEW
1. What programs of the Department of Health are you
implementing in the barangay?
2. How do you disseminate information to the community
members?
3. How effective are the implementation of the health
programs against communicable, emerging, and re
emerging diseases?
4. What are the indicators of the programs effectiveness?
Objectives:
The program aims to:
1. Reduce public health impact of emerging and re-emerging
infectious diseases; and
2. Strengthen surveillance, preparedness, and response to
emerging and re-emerging infectious diseases.
Program Strategies:
The DOH, in collaboration with its partner organizations/agencies,
employs the key strategies:
1. Development of systems, policies, standards, and guidelines for
preparedness and response to emerging diseases;
2. Technical Assistance or Technical Collaboration;
3. Advocacy/Information dissemination;
4. Intersectoral collaborations;
5. Capability building for management, prevention and control of
emerging and re-emerging diseases that may pose
epidemic/pandemic threat; and
6. Logistical support for drugs and vaccines for meningococcemia
and anti-viral drugs and vaccine for Pandemic Influenza
Preparedness.
DEPARTMENT OF EDUCATION
UNITED STATES AGENCY FOR INTERNATIONAL
DEVELOPMENT